An improved process for preparing Nhydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) - phenoxy] -pentoxy }-benzamidine

Details for Australian Patent Application No. 2005260326 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/004368 Priority application(s): WO2006/004368

23 October 2008 Application Accepted

Published as AU-B-2005260326

19 February 2009 Standard Patent Sealed

3 September 2009 Amendment Made

The nature of the amendment is: Amend the patentee name to Dong Wha Pharmaceutical Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.